Hubei Jumpcan Pharmaceutical News and Activities
Presence
Hubei Jumpcan Pharmaceutical makes and sells prescription medicines and health products. Its main products include pediatric drugs, injections, and traditional medicines for hospitals, clinics, pharmacies, and patients in China.
Hubei Jumpcan Pharmaceutical products and services overview:
- Pediatric medicines
- Prescription drugs
- Traditional medicines
- Injections
- Health supplements
- Pharmaceutical manufacturing
Revenue: ~$550 million
Employees: 3,200
Headquarters: Jingmen, China
Hubei Jumpcan Pharmaceutical is one of the...
Hubei Jumpcan Pharmaceutical is a company listed under the stock ticker 600566 (CN).
Executives
View the org chart displaying its 9 main executives
Most searched biographies at Hubei Jumpcan Pharmaceutical
- Fei Cao, Vice Chairman of the Board and General Manager
- Longxiang Cao, Chairman of the Board
- Hong Yao, Director
Create your alert
to follow the executive moves at Hubei Jumpcan Pharmaceutical.
Pharmaceuticals
Hubei Jumpcan Pharmaceutical has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Corden Pharma has announced the acquisition of AmbioPharm (posted on June 5 2026).
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Hubei Jumpcan Pharmaceutical
Social media about Hubei Jumpcan Pharmaceutical
- Hubei Jumpcan Pharmaceutical on Wikipedia, Google News & Yahoo Finance
- Hubei Jumpcan Pharmaceutical on LinkedIn, X (Twitter) & YouTube
